Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Oropharyngeal pain, Spondylitis
Clinical narrative: Heart damage; Lost voice, Could not talk or speak/ Voice is hoarse and raspy/ Vocal cords have shrunken; Pain in neck/ Svere neck pain; Throat pain; Felt cold; Sweating profusely; Slight disc problem in neck/ Disc damage fron previous Neck injury; He does not know how many months that he has not been able to sleep; Had a little Arthritis in neck; Neck injury; Cramping in my ankles; Headache; Covid-19; This spontaneous case was reported by a patient and describes the occurrence of CARDIAC DISORDER (Heart damage), APHONIA (Lost voice, Could not talk or speak/ Voice is hoarse and raspy/ Vocal cords have shrunken), NECK PAIN (Pain in neck/ Svere neck pain), OROPHARYNGEAL PAIN (Throat pain) and FEELING COLD (Felt cold) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    The patient's past medical history included Neck injury (Disc damage from previous neck injury). Concurrent medical conditions included Intervertebral disc injury (Disc damage from previous neck injury).   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form and fourth dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. and third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. In February 2023, the patient experienced COVID-19 (Covid-19). On an unknown date, the patient experienced CARDIAC DISORDER (Heart damage), APHONIA (Lost voice, Could not talk or speak/ Voice is hoarse and raspy/ Vocal cords have shrunken), NECK PAIN (Pain in neck/ Svere neck pain), OROPHARYNGEAL PAIN (Throat pain), FEELING COLD (Felt cold), HYPERHIDROSIS (Sweating profusely), INTERVERTEBRAL DISC DISORDER (Slight disc problem in neck/ Disc damage fron previous Neck injury), INSOMNIA (He does not know how many months that he has not been able to sleep), SPONDYLITIS (Had a little Arthritis in neck), NECK INJURY (Neck injury), MUSCLE SPASMS (Cramping in my ankles) and HEADACHE (Headache). In February 2023, COVID-19 (Covid-19) had resolved. At the time of the report, CARDIAC DISORDER (Heart damage), APHONIA (Lost voice, Could not talk or speak/ Voice is hoarse and raspy/ Vocal cords have shrunken), NECK PAIN (Pain in neck/ Svere neck pain), OROPHARYNGEAL PAIN (Throat pain), FEELING COLD (Felt cold), HYPERHIDROSIS (Sweating profusely), INTERVERTEBRAL DISC DISORDER (Slight disc problem in neck/ Disc damage fron previous Neck injury), INSOMNIA (He does not know how many months that he has not been able to sleep), SPONDYLITIS (Had a little Arthritis in neck), NECK INJURY (Neck injury), MUSCLE SPASMS (Cramping in my ankles) and HEADACHE (Headache) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.  All medical reports, tests and physician visits were reviewed, validated and confirmed and no physician could not find anything wrong because nothing was wrong.   Company Comment: This spontaneous case concerns a male patient (age not specified) with a medical history of disc damage from previous neck injury, who experienced the unexpected non-serious AESI of Spondylitis and non-serious events of Intervertebral disc disorder, Neck injury and Neck pain that occurred in context with second dose of mRNA-1273 vaccine in covid-19 vaccination series. Patient have received third and fourth doses with Tozinameran after vaccination with mRNA-1273 in covid-19 vaccination series. Patients medical history could be confounding. No further information on clinical course, investigations and treatment received was available in the report. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.